CHINA BIOLOGIC PRODS INC's ticker is CBPOXXXX and the CUSIP is 16938C106. A total of 140 filers reported holding CHINA BIOLOGIC PRODS INC in Q4 2016. The put-call ratio across all filers is 1.49 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $4,734,000 | +13.0% | 41,858 | 0.0% | 0.17% | +20.4% |
| Q1 2017 | $4,191,000 | -6.9% | 41,858 | 0.0% | 0.14% | -15.0% |
| Q4 2016 | $4,501,000 | -13.6% | 41,858 | 0.0% | 0.17% | -12.6% |
| Q3 2016 | $5,210,000 | +17.1% | 41,858 | 0.0% | 0.19% | +51.6% |
| Q2 2016 | $4,450,000 | -7.1% | 41,858 | 0.0% | 0.13% | -6.0% |
| Q1 2016 | $4,792,000 | -25.2% | 41,858 | -6.9% | 0.13% | -19.3% |
| Q4 2015 | $6,405,000 | +8.1% | 44,958 | -31.8% | 0.17% | +21.2% |
| Q3 2015 | $5,924,000 | -0.4% | 65,958 | +27.7% | 0.14% | +12.3% |
| Q2 2015 | $5,948,000 | -14.3% | 51,654 | -28.9% | 0.12% | -19.2% |
| Q1 2015 | $6,939,000 | +120.4% | 72,648 | +55.2% | 0.15% | +132.3% |
| Q4 2014 | $3,148,000 | +69.2% | 46,823 | +35.7% | 0.06% | +85.7% |
| Q3 2014 | $1,861,000 | – | 34,497 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SPQ Asia Capital Ltd | 287,277 | $35,760,000 | 28.32% |
| WARBURG PINCUS LLC | 6,674 | $830,780,000 | 13.45% |
| Ariose Capital Management Ltd | 238,841 | $27,689,000 | 7.56% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 12,600 | $1,568,000 | 4.48% |
| RUDMAN ERROL M | 37,001 | $4,606,000 | 3.72% |
| INDUS CAPITAL PARTNERS, LLC | 245,237 | $30,527,000 | 2.89% |
| Ativo Capital Management LLC | 93,784 | $11,674,000 | 2.70% |
| OBERWEIS ASSET MANAGEMENT INC/ | 63,305 | $7,880,000 | 2.27% |
| Point72 Hong Kong Ltd | 31,500 | $3,921,000 | 2.14% |
| Cormorant Asset Management, LP | 112,867 | $14,050,000 | 1.55% |